Brief: Altimmune Secures Up To $100 Mln In Credit Facility From Hercules Capital
13/05/2025 12:49
May 13 (Reuters) - Altimmune Inc ALT.O: ALTIMMUNE SECURES UP TO $100 MILLION IN CREDIT FACILITY FROM HERCULES CAPITAL ALTIMMUNE INC - PEMVIDUTIDE PHASE 2B TRIAL DATA EXPECTED Q2 2025 Source text: ID:nGNX9RXl38 Further company coverage: ALT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altimmune
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial (updated)